James Thomas Brewster II

Chief Executive Officer at Cime Therapeutics.

Raised on Cime Therapeutics filings

$2.1M

of $2.5M offered across 1 Form D filing

Company

Biotech · Denver, CO

Shielded stem cells for blood disease transplants

Shielded stem cells for blood disease transplants

Cime Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Mar 21, 2025	Option to acquire	$2.1M/ $2.5M	Form D

Also named on Cime Therapeutics filings